Essex Woodlands Management, Inc. Long-Term Concentrated

CIK: 0001542339 · Show all filings

Period: Q2 2015 (← Previous) (Next →)

Filing Date: Aug 11, 2015

Total Value ($000): $554,049 (100.0% shares, 0.0% debt)

Holdings (7)

— REVANCE THERAPEUTICS INC 26.5%

Value ($000) $146,854 Shares 4,592,047 Est. Cost $31.50 Unrealized —

— ABIOMED INC 25.5%

Value ($000) $141,319 Shares 2,150,000 Est. Cost $21.56 Unrealized —

— CORIUM INTL INC 23.1%

Value ($000) $128,047 Shares 9,353,304 Est. Cost $7.77 Unrealized —

— ENTELLUS MED INC 17.8%

Value ($000) $98,647 Shares 3,813,197 Est. Cost $21.90 Unrealized —

— ENDOLOGIX INC 4.5%

Value ($000) $24,875 Shares 1,257,468 Est. Cost $18.00 Unrealized —

— ACURA PHARMACEUTICALS INC 1.7%

Value ($000) $9,684 Shares 9,871,985 Est. Cost $1.82 Unrealized —

MNOV MEDICINOVA INC 0.8%

Value ($000) $4,623 Shares 1,170,370 Est. Cost $2.95 Unrealized +33.9%

Ticker	Issuer	Shares	Value ($000)	%	Est. Cost	Unrealized	Class	CUSIP
—	REVANCE THERAPEUTICS INC	4,592,047	$146,854	26.5%	$31.50	—	COM	761330109
—	ABIOMED INC	2,150,000	$141,319	25.5%	$21.56	—	COM	003654100
—	CORIUM INTL INC	9,353,304	$128,047	23.1%	$7.77	—	COM	21887L107
—	ENTELLUS MED INC	3,813,197	$98,647	17.8%	$21.90	—	COM	29363K105
—	ENDOLOGIX INC	1,257,468	$24,875	4.5%	$18.00	—	COM	29266S106
—	ACURA PHARMACEUTICALS INC	9,871,985	$9,684	1.7%	$1.82	—	COM NEW	00509L703
MNOV	MEDICINOVA INC	1,170,370	$4,623	0.8%	$2.95	+33.9%	COM NEW	58468P206